Announcing a new publication for Acta Materia Medica journal. Phosphodiesterase-4 (PDE4), a member of the phosphodiesterase superfamily, has highly important roles in cyclic nucleotide signaling pathways and a variety of skin disorders. Blocking PDE4 activity with PDE4 inhibitors increases intracellular cAMP levels and effectively relieves the skin inflammatory phenotype of psoriasis. However, traditional PDE4 inhibitors may cause adverse effects such as gastrointestinal reactions.
Natural products typically exhibit safety profiles and structural novelty, which are particularly advantageous for drug discovery. LW, a derivative of the natural product Moracin M, was found to have favorable PDE4 inhibitory activity (PDE4 IC50 = 54 nM). Examination of LW in psoriasis treatment demonstrated good anti-inflammatory effects in cellular models. In an imiquimod-induced mouse model, LW treatment markedly improved psoriatic symptoms, as evidenced by increased PASI scores and ameliorated skin pathology. Moreover, LW significantly downregulated Inflammatory factors in the serum and alleviated spleen damage.
Therefore, LW has substantial therapeutic potential, through effectively decreasing inflammatory factor levels and ameliorating psoriatic skin phenotypes. These findings support LW as a potential candidate compound for developing new psoriasis treatments.
Read More: https://www.scienceopen.com/hosted-document?doi=10.15212/AMM-2024-0086
Acta Materia Medica welcomes the submission of research articles, review articles, databases, mini reviews, commentaries, editorials, short communications, case report articles and study protocols.
Submission Process
Submissions to Acta Materia Medica are made using ScholarOne, the online submission and peer review system. Registration and access are available at https://mc04.manuscriptcentral.com/ammed
Queries about the journal can be sent to editorialoffice@amm-journal.org.
Please visit https://amm-journal.org/ to learn more about the journal.
Editorial Board: https://amm-journal.org/index.php/editorial-board/
There are no author submission or article processing fees.
Follow Acta Materia Medica on Twitter https://twitter.com/AMM_journal; Facebook (https://www.facebook.com/AMMjournal)
eISSN 2737-7946
Liru Chen, Deyan Wu and Sen Wang et al. Moracin M derivative targeting PDE4 for the treatment of psoriasis. Acta Materia Medica. 2025. Vol. 4(2):293-301. DOI: 10.15212/AMM-2024-0086